Markets:

Overview

News

Currencies

International

Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

2.240 +0.070 (+3.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cerus Corporation - Common Stock

< Previous 1 2 3 4 Next >

Uncertain Times ↗

December 15, 2021

The UK inflation rate last month was 5.1%, not a good omen.

Via Talk Markets

86 Biggest Movers From Yesterday ↗

November 04, 2021

Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....

Via Benzinga

A Look Into Cerus Debt ↗

May 17, 2021

Shares of Cerus (NASDAQ:CERS) fell by 20.75% in the past three months. Before we understand the importance of debt, let us look at how much debt Cerus has. Cerus's Debt...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 03, 2021

Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...

Via Benzinga

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Cerus Posts Lower Than Expected Q3 Loss; Raises FY21 Sales Guidance ↗

November 03, 2021

Cerus Corporation (NASDAQ: CERS) reported Q3 sales of $42.1 million, +44% Y/Y, beating the consensus of $37.27 million. Product revenue reached $36.13 million, +53%,...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 03, 2021

Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

25 Stocks Moving in Wednesday's Pre-Market Session ↗

November 03, 2021

Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...

Via Benzinga

Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

CERS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Delta Variant Fears Continue ↗

September 09, 2021

The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher.

Via Talk Markets

88 Biggest Movers From Yesterday ↗

August 05, 2021

Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 04, 2021

Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6...

Via Benzinga

30 Stocks Moving in Wednesday's Pre-Market Session ↗

August 04, 2021

Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 34.8% to $1.84 in pre-market trading after gaining around 3% on Tuesday. Wheeler Real Estate Investment Trust,...

Via Benzinga

Cerus Stock Gains As Q2 Earnings Match Expectations, Raises FY21 Sales Guidance ↗

August 04, 2021

Cerus Corporation (NASDAQ: CERS) reported second-quarter sales of $37.8 million, +41% Y/Y in line with the consensus. Product revenue reached $31.5 million, compared to...

Via Benzinga

Topics Earnings

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Cerus Corporation (CERS) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

CERS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 03, 2021

Gainers Cerus (NASDAQ:CERS) shares incre...

Via Benzinga

14 Stocks Moving In Tuesday's After-Hours Session ↗

August 03, 2021

RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY21 EPS and sales guidance above...

Via Benzinga

Recap: Cerus Q2 Earnings ↗

August 03, 2021

Shares of Cerus (NASDAQ:CERS) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to...

Via Benzinga

Delta Defeats Bulls ↗

July 19, 2021

Stocks tended to crash without rhyme or reason.

Via Talk Markets

Weak Week ↗

July 16, 2021

Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.

Via Talk Markets

Stocks That Hit 52-Week Lows On Wednesday ↗

July 14, 2021

Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was the largest firm by market cap to set a new 52-week low....

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

Cramer Gives His Opinion On AT&T, Cemex And More ↗

July 11, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a fan of AT&T Inc. (NYSE: T). For growth, he would go with T-Mobile Us Inc (NASDAQ: TMUS) and...

Via Benzinga

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

End Of June ↗

June 30, 2021

Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.

Via Talk Markets

Topics Initial Public Offering

4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60% ↗

May 22, 2021

The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and...

Via Talk Markets

Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript ↗

May 05, 2021

CERS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cerus Corporation - Common Stock (NQ:CERS)

Headline News about Cerus Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today